Gedeborg, R. et al. 2022. Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study. Acta Oncologica. 61, 3 (Mar. 2022), 328–332. DOI:https://doi.org/10.1080/0284186X.2021.2023215.